WARSAW, Ind., Oct. 28, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (ZBH), a global medical technology leader, today announced plans for the broad commercial launch of the Z1™ Femoral Hip System ...

Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the heels of a warning from the U.S. Food and Drug Administration (FDA), ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Zimmer Biomet issued a field safety corrective notice ...

WARSAW, Ind., Oct. 28, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the U.S. Food and Drug Administration (FDA) has ...

This week, FDA issued a safety communication connected to Zimmer Biomet’s CPT Hip System Femoral Stem after finding increased risk of thigh bone fracture — postoperative periprosthetic femoral ...

May 2 (Reuters) - Medtech firm Zimmer Biomet Holdings (ZBH.N), opens new tab beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used ...

(RTTNews) - The U.S. Food and Drug Administration has issued a safety alert about the increased risk of thigh bone fracture after surgery with the use of the Zimmer Biomet CPT Hip System, which was ...

Zimmer Biomet Holdings, Inc. ZBH recently announced the signing of a definitive agreement to acquire OrthoGrid Systems, Inc., a privately-held medical technology company focused on artificial ...

iTaperloc ® Complete and iG7 ™ Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant surface to help address the issue of Periprosthetic Joint ...